한글목차

세계 체외진단(IVD) 시장 규모는 2024년 947억 달러에서 예측 기간 동안 연평균 8.4%로 성장하여 2029년 말에는 1,419억 달러에 달할 것으로 예상됩니다.

면역화학 IVD 시장은 2024년 328억 달러에서 예측 기간 동안 CAGR 5.5%, 2029년 말까지 430억 달러에 달할 것으로 예상되며, POC 검사 IVD 시장은 2024년 232억 달러에서 CAGR 10.6%, 2029년 말까지 384억 달러에 달할 것으로 예상됩니다. 말에는 384억 달러에 달할 것으로 예상됩니다.

세계의 체외진단(IVD) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 신흥 기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장과 기술 배경

• 체외진단(IVD) 기술
• 개요
• IVD 엘리먼트 분류
• IVD 기술과 품질 관리의 중요성
• IVD와 생체 진단의 차이
• IVD 업계 규제
• 각국의 IVD 제품 규제

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 노인 인구 증가 : 진단 처치에 대한 의존
• IVD에서 AI의 통합
• 만성질환 만연
• Point of Care 검사(POCT) 품질 향상
• 시장 성장 억제요인
• 기술 제품 패키징 관련 과제
• 배송 비용 증가와 서비스 문제
• 실험 조수의 실험 기구나 소모품 취급 능력 결여
• 시장 기회
• 재택 케어 검사 디바이스 증가
• POCT 유닛 수요
• AI와 IoT에 대한 수요 상승

제4장 신기술과 개발

• IVD 시장의 신기술
• AI
• 개선된 오래된 IVD 기술
• 액체 생검
• 자동 IVD 디바이스
• IVD의 새로운 발전
• FDA 승인
• 맞춤형 의료 수요 증가
• 실험실 자동화와 디지털 헬스 플랫폼
• IVD 디바이스의 휴대성 옵션
• 암 진단을 위한 홈케어 키트
• FDA 승인 IVD 디바이스 : AI 대응

제5장 시장 세분화 분석

• 세분화 내역
• 시장 분석 : 기술별
• 면역화학
• POC 테스트
• 혈액
• 분자진단
• 조직 진단
• 임상 미생물
• 시장 분석 : 용도별
• 당뇨병
• 신장
• 혈당치 평가와 모니터링(BGEM)
• 종양
• 심장병
• 감염증
• 기타
• 시장 분석 : 최종사용자별
• 진단 실험실
• 병원·진료소
• POC 센터
• 기타
• 지역적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제6장 경쟁 정보

• 세계의 기업 순위 분석
• 중국의 주요 IVD 기업 개요
• 협정, 협력, 파트너십
• IVD 기업과 스타트업

제7장 체외진단(IVD) 업계의 지속가능성 : ESG 관점

• IVD 제조 업계의 ESG의 중요성
• IVD 업계의 ESG 실천
• 환경 퍼포먼스
• 사회적 퍼포먼스
• 거버넌스 퍼포먼스
• ESG 개발의 기업의 역할
• ESG 리스크 평가
• BCC에 의한 견해

제8장 부록

• 조사 방법
• 참고문헌
• 기업 개요
• ABBOTT
• BD
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• DANAHER CORP.
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE LTD.
• HOLOGIC INC.
• JSR CORP.
• QUIDELORTHO CORP.
• SIEMENS HEATHNIEERS AG
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

The immunochemistry IVD market is expected to grow from $32.8 billion in 2024 and is projected to reach $43.0 billion by the end of 2029, at a CAGR of 5.5% during the forecast period of 2024 to 2029.

The POC testing IVD market is expected to grow from $23.2 billion in 2024 and is projected to reach $38.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.

Report Scope

This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market's competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.

In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.

The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.

Report Includes

• 41 data tables and 54 additional tables
• Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region
• Assessment of market dynamics such as drivers, restraints and opportunities
• Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
• Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests
• A discussion on ESG challenges and practices in the industry
• Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches
• Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market and Technology Background

• Introduction
• In vitro Diagnostics Technology
• Overview
• Classification of In Vitro Diagnostic Elements
• Importance of In Vitro Diagnostics Technologies and Quality Control
• Difference Between In Vitro and In Vivo Diagnostics
• Regulations in the IVD Industry
• Regulation of IVD Products in Different Countries

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rise in Population of Older Adults: Dependence on Diagnosis Procedures
• Integration of Artificial Intelligence in Vitro Diagnostics
• Rising Prevalence of Chronic Diseases
• Improving the Quality of Point-of-Care Testing (POCT)
• Market Restraints
• Challenges Associated with Technologies Product Packaging
• Increases in Shipping Costs or Service Issues
• Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
• Market Opportunities
• Rise in Home Care Testing Devices
• Demand for Point-of-Care (POC) Testing Units
• Growing Demand for AI and the Internet of Things

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies in the IVD Market
• Artificial Intelligence
• Modified Old IVD Techniques
• Liquid Biopsy
• Automated In Vitro Diagnostic Devices
• Emerging Developments in In Vitro Diagnostics
• FDA Approval
• Rise in Demand for Personalized Medicine
• Lab Automation and Digital Health Platform
• Portability Option in IVD Devices
• Home Care Kits for Cancer Diagnosis
• FDA Approved In Vitro Diagnostic Devices: AI Enabled

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Technology
• Immunochemistry
• POC Testing
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Microbiology
• Market Analysis by Application
• Diabetes
• Nephrology
• Blood Glucose Evaluation and Monitoring (BGEM)
• Oncology
• Cardiology
• Infectious Diseases
• Other Applications
• Market Analysis by End User
• Diagnostic Laboratory
• Hospitals and Clinics
• Point-of-Care (POC) Centers
• Other End Users
• Geographical Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Chapter 6 Competitive Intelligence

• Introduction
• Global Analysis of Company Market Ranking
• Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
• Agreements, Collaborations and Partnerships
• bioMerieux Agreements
• Siemens Healthineers and Sysmex Enter into a Global Agreement
• Roche Enters into Agreement with Path AI
• Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
• In Vitro Diagnostics Companies and Start-Ups in 2021-2023
• Diagopreutic Private Limited
• Diatherax
• IPLEXMED
• Magnify Bioscience Inc.

Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective

• Importance of ESG in In Vitro Diagnostics Manufacturing Industry
• ESG Practices in the In Vitro Diagnostics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Company Role in ESG Development
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 8 Appendix

• Research Methodology
• References
• Company Profiles
• ABBOTT
• BD
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• DANAHER CORP.
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE LTD.
• HOLOGIC INC.
• JSR CORP.
• QUIDELORTHO CORP.
• SIEMENS HEATHNIEERS AG
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.